Tissue engineering repair of annulus fibrosus (AF) defects has the potential to prevent disability and pain from intervertebral disc (IVD) herniation and its progression to degeneration. Clinical translation of AF repair methods requires assessment in longterm large animal models. An ovine AF injury model was developed using cervical spinal levels and a biopsy-type AF defect to assess composite tissue engineering repair in 1-month and 12-month studies. The repair used a fibrin hydrogel crosslinked with genipin (FibGen) to seal defects, poly(trimethylene carbonate) (PTMC) scaffolds to replace lost AF tissue, and polyurethane membranes to prevent herniation. In the 1-month study, PTMC scaffolds sealed with FibGen herniated with polyurethane membranes. When applied alone, FibGen integrated with the surrounding AF tissue without herniation, showing promise for long-term studies. The 12-month long-term study used only FibGen which showed fibrous healing, biomaterial resorption and no obvious hydrogel-related complications. However, the 2 mm biopsy punch injury condition also exhibited fibrotic healing at 12 months. Both untreated and FibGen treated groups showed equivalency with no detectable differences in histological grades of proteoglycans, cellular morphology, IVD structure and blood vessel formation, biomechanical properties including torque range and axial range of motion,
Pfirrmann grade, IVD height, and quantitative scores of vertebral body changes from clinical computed tomography. The biopsy-type injury caused endplate defects with a high prevalence of osteophytes in all groups and no nucleus herniation, indicating that the biopsy-type injury requires further refinement, such as reduction to a slittype defect that could penetrate the full depth of the AF without damaging the endplate. Results demonstrate translational feasibility of FibGen for AF repair to seal AF defects, although future study with a more refined injury model is required to validate the efficacy of FibGen before translation. Defects of the intervertebral disc (IVD), which include injuries to the annulus fibrosus (AF) and herniation, are highly associated with disabling back and neck pain. 1, 2 Extrusion of nucleus pulposus or AF tissue as an IVD herniation is a known and specific cause of pain and disability. 3 Surgery can relieve disability from the neuropathy but does not repair the AF. The urgent clinical need for AF repair stems from the risk of reherniation following discectomy surgery, with reherniation rate as high as 27% for defects larger than 6 mm, and an average rate of 15%. 4 Unrepaired AF defects can also lead to progression of IVD degeneration as an additional source of pain and disability.
Developing AF repair strategies is therefore a research priority, and the use of large animal models of AF injury and repair is necessary to accelerate translation of AF repair strategies. The present work describes progress toward establishing and translating AF repair models using a short-term (1-month) and long term (12-month) ovine model of AF injury.
Ovine IVDs are a popular IVD pathology model [5] [6] [7] [8] [9] due to their size, and the biochemical, cellular, and mechanical environment. Lumbar ovine IVDs are approximately 1/3 the size of human IVDs, 10 and capture the diffusion limited nutrient and oxygen transport environment observed in human IVDs. 11, 12 As in human, 13 ovine nucleus pulposus cells do not express a notochordal phenotype during skeletal maturity. 14 16 Annular closure devices include sutures, such as the unavailable Xclose Tissue Repair System (Anulex Technologies, Minnetonka, Minnesota) and the similar but available AnchorKnot, (Anchor Orthopedics, Mississauga, Ontario, Canada), 17 and a mesh barrier which anchors to the vertebral body called Barricaid (Intrinsic Therapeutics, Woburn, Massachusetts). The Barricaid is under current clinical investigation with promising results including decreased disability, increased IVD height and reduced rate of recurrent IVD herniation, but had a higher frequency of endplate complications at 2 18 ) and 3 years. 19 In addition to mechanical repairs, there are a range of AF replacement materials including electrospun poly-e-caprolactone 20, 21 and hyaluronic acid with polyethylene 22 (material properties reviewed in Reference 23). Void filling biomaterials which can be injected with or without cells, such as collagen, 24 were recently reviewed in Reference 25. While many biomaterials exist for AF repair, those with regulatory approval can be further improved, and those that are not approved need further validation. Due to the high clinical need, AF repair remains an active area of research (reviewed in 26, 27 ) , and this study uses a preclinical large animal model to evaluate multiple biomaterial repair strategies for AF repair. Fibrin crosslinked with genipin (FibGen) is an adhesive hydrogel optimized for AF repair by tuning its formulation to match the shear modulus of human AF. 28 Previous in vitro studies reported a reduction of IVD height loss in a bovine AF defect organ culture model 29 and low herniation risk in ex vivo mechanical testing of the bovine IVD. 30 A polytrimethylene carbonate (PTMC) based porous scaffold showed the ability to immediately restore the IVD height after implantation in an AF defect of a bovine loaded organ culture model, 31 and offers potential for delivery of bioactive factors and cells. A polyurethane (PU) membrane sutured onto the AF was used to prevent herniation of this PTMC scaffold, which remained in place within the AF defect for 2 weeks in an organ culture bioreactor system under mechanical load. 31 The success of FibGen adhesive, PTMC scaffold, and the PU membrane in prior ex vivo testing motivate their in vivo use in a large animal model as an important next step in translation for an AF repair strategy.
The purposes of this in vivo study were (a) to perform a 1-month screening study to evaluate the feasibility of FibGen, PU membrane, and PTMC as a composite strategy for AF repair in vivo; and (b) to perform a 12-month long-term study of biopsy punch AF injury and to evaluate the performance of FibGen. The 1-month screening study compared the histological appearance of injured cervical IVDs treated with three different composite repair strategies: injectable FibGen only, FibGen with membrane, and FibGen with scaffold and membrane. The long-term study compared histological appearance, degeneration using Pfirrmann grade, IVD height, vertebral body changes using computed tomography (CT), and biomechanical behavior of untreated and FibGen treated injured cervical IVDs.
| MATERIALS AND METHODS

| Animals and pre-op care
The studies were approved by the relevant Swiss authorities (Cantonal authorities in Graubünden, Switzerland; Permission # 40/2014). Four skeletally mature female Swiss White Alpine sheep (age range: 2-4 years old, weight range 51.5-63 kg) were enrolled in the screening study; while 10 sheep (age range: 3-5 years old, weight range 74-89 kg) were enrolled in the long-term study. Prior to the start of the study, the animals were acclimatized for 2 weeks at the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) approved facility. During this time, they were group housed under a 12 hours dark/ light cycle and fed with hay, mineral lick, and hand-fed grain to gain familiarity with caregivers. Before the surgery, the sheep were assessed to be in good health based on a complete physical clinical assessment by a veterinarian.
2.2 | Preclinical model overview
| Screening study
In each sheep (four animals), a 2 mm annular defect was created with a biopsy punch in four cervical levels: C2-C3, C3-C4, C4-C5, and C5-C6. IVDs in the Injured group were not repaired (n = 4). The biopsy punch injury was used because it is repeatable, clinically relevant and has precedent in the literature. 31, 32 IVDs in the treatment groups were repaired by either injection of FibGen (n = 4), injection of FibGen and suture of PU membrane onto the defect (n = 4), or implantation of PTMC scaffold with sealing by FibGen and suturing of PU membrane (n = 4) ( Figure 1G ). Treatments were rotated systematically by level (C2-C5) to avoid potential level bias. Long-term study: In each sheep (10 animals), a 2 mm annular injury was created with a biopsy punch in three cervical levels: C2-C3, C3-C4, and C4-C5. IVDs at levels C5-C6 and C6-C7 were used as intact controls (termed Intact group, n = 20). In each sheep, one cervical IVD (from C2-C5) which had an annular defect was not repaired (termed Injured group, n = 10).
Immediately after annular injury creation, two cervical IVDs (from C2-C5) were repaired with an injection of FibGen (termed FibGen group, n = 20) ( Figure 1H ). Assignment to Injured or FibGen groups was rotated systematically by level to avoid potential level bias such that Injured group had 3 C2-C3, 4 C3-C4, and 3 C4-C5 and the FibGen group had 7 C2-C3, 6 C3-C4, and 7 C4-C5.
F I G U R E 1 Surgical approach and study design of the long-term study. A, Surgical approach was guided radiographically using a C-arm. B, The intervertebral disc was exposed with an anterolateral approach. C, Radiograph of C2-C7 demonstrating convexity of the inferior endplate. D, The three cervical (C2-C5) IVDs of 10 animals were injured with a biopsy punch and two were repaired with FibGen. E, The exposed intervertebral IVD was injured with a 2 mm diameter biopsy punch. F, The FibGen repair was delivered with a mixing tip syringe. G, All Injured untreated (n = 10) and FibGen repaired levels (n = 20) from 10 animals were subjected to computed tomography and magnetic resonance imaging and were evenly distributed to histological or biomechanical analysis For the surgery, the sheep were placed in dorsal recumbency and, under aseptic technique, the cervical levels were exposed through a ventral approach from the right side. 32 A longitudinal incision and blunt preparation between the sternocleidoideus and longus colli muscles/carotid sheath (lateral) and the trachea (medial) exposed the anterior aspect of the IVD (C2/3-C6/C7). After confirmation of the correct level with the Carm X-ray ( Figure 1A) , IVDs from C2-C5 (C2-C6 for the screening study) ( Figure 1C sheep under the same conditions as listed above. Animal welfare was assessed using a score sheet twice daily for 3 days, daily for four additional days, and then once weekly.
| Surgical intervention
| AF repair
FibGen was prepared freshly prior to surgery by dissolving fibrinogen (Sigma-Aldrich) in filtered (12 μm) Phosphate Buffered Saline (PBS) at 140 mg/mL. The mixture was exposed to ultraviolet light for 1 hour.
Thrombin (40 μL of 1000 U/mL) (Sigma-Aldrich, Buchs, Switzerland) was added to 226.8 μL of PBS. Genipin (Wako Chemicals USA Inc., Richmond, Virginia) dissolved in dimethyl sulfoxide (20.25 μL of 6 mg/mL) was added to the thrombin/PBS. The fibrinogen (0.8 vol. fraction) and thrombin/PBS/genipin (0.2 vol. fraction) were concomitantly injected with a 4:1 dual barrel syringe (Pearson Dental, Sylmar, California) to completely fill the annular defect ( Figure 1F ).
Screening Study: PTMC scaffolds and PU films used for the screening study were prepared as described elsewhere. 31 For the FibGen repair (n = 4), FibGen was injected as described above. For the FibGen + membrane repair (n = 4), FibGen was injected into the defect which was sealed by suturing a PU film onto the surrounding AF tissue (4-point suture) using a 4-0 Prolene (Ethicon, Somerville, New Jersey).
For the FibGen + membrane + scaffold repair (n = 4), a conical PTMC scaffold of 2 mm (outer side) and 3 mm (inner side) in diameter and 4 mm length was press-fit into the AF defect and filled with FibGen hydrogel. The defect was then covered with a PU film sutured onto the surrounding AF tissue as outlined above.
| In vivo clinical CT
In the long-term study, in vivo computed tomography (CT) scans of the cervical IVDs (C2-C7) were acquired at a resolution of 0.63 mm using 130 kV potential, an exposure of 180 mAs and a slice thick- Figure S1 ).
| Euthanasia and sample harvest
The animals of the screening study were euthanized after 1 month, while the animals of the long-term study were euthanized after repaired IVDs were fixed in ethanol ( Figure 1G ). 15 Then, each specimen was subjected to torsional loading at two rotations: first ±2 , then ±4 at three frequencies: 0.1, 1, and 2 Hz. The rotation was informed by the limits of human physiological motion which are ±4 . 36 The number of cycles were: 20 cycles for 0.1 Hz, 30 cycles for 1 Hz, and 100 cycles for 2 Hz. However, at (Figure 2A-D) . In FibGen treated defects, large clefts were noted in 1/4 cases, while presence of vessels was also identified similar to the untreated defects ( Figure 2E-H) . Sealing of the FibGen treated defect with a PU film sutured onto the AF tissue did not influence the histological outcome; in fact, there were signs of displacement of the PU membrane in most cases ( Figure 2I-L) . Similarly, the PTMC scaffold did not remain stable in the defect but was dislocated in most cases ( Figure 2M-P) . In all treatment groups, discontinuation of the endplate was evident.
| MRI
This damage was observed in 1-2 cases/group and was mainly (Figure 4 , Table S1 ). No differences were detected between the Injured and FibGen treated groups for any category (Figure 4A-E) nor the sum score ( Figure 4F) , although FibGen had a statistical trend of higher structure/lesion grade (P = .06) ( Figure 4B ). Few FibGen and 
| In vivo clinical CT imaging
The Injured and FibGen groups showed an increase in clinical CT score compared to 0-month baseline ( Figure 6A ). All samples had a score of 0 at 0 months, indicating no bone formation ( Figure 6B ). For the FibGen group, the score was significantly higher at 3 months (P = .01), 6 months (P = .005), 9 months (P = 3.1 × 10 −5 ) and 12 months (P = 5.8 × 10 −5 ). In the Injured group, the score was significantly higher at 9 months (P = .02) and 12 months (P = .01), with a trend of significance at 6 months (P = .07). When comparing between groups at each timepoint, the Intact group had lower score at 3, 6, 9, and 12 months, compared to the Injured (P = .006, 5.4 × 10 −5 , 5.4 × 10 −5 , 0.00019) and FibGen groups (P = .0003, 5.4 × 10 −5 , 5.4 × 10 −5 , 6.7 × 10 −5 ). 3D reconstructions from biomechanics specimens, which underwent microtomography in addition to the clinical CT, demonstrate increased bone formation with increased clinical CT score ( Figure S1 ).
| MRI
The Pfirrmann grade of the Injured (P < .001) and FibGen (P < .001,) groups were lower than the Intact samples, and no difference was detected between Injured and FibGen specimens (P = .46) ( Figure 7A , D). The IVD height of Intact group was less than that of Injured (P < .002) and FibGen (P < .001) groups ( Figure 7B ). The disc height index, which is disc height normalized by the inferior vertebral body height, was higher for Intact samples compared to FibGen (P < .002) and Injured (P < .002) ( Figure 7C ).
| Biomechanical analysis
No differences were detected for torsional or axial biomechanical behavior of FibGen and Injured IVDs, as seen in representative torque-rotation and force-displacement curves from Injured (level C2-C3) and FibGen (level C3-C4) treated IVDs (Figure 8A,F) . Previous results suggest intact IVDs from C2 to C3 and C3 to C4 have comparable mechanical behavior. 32 There were no detected differences in torque range ( Figure 8B,D) , neutral zone length ( Figure 8C ,E), axial range of motion ( Figure 8G ), axial neutral zone length ( Figure 8H ), torsion stiffness nor axial compliance (Table 1) .
| DISCUSSION
This study applied an ovine cervical IVD biopsy injury model to evaluate the in vivo response of multiple AF repair methods. An 1-month screening study evaluated multiple composite AF repair strategies for their herniation risk using histological evaluation as output. The longterm 12-month study evaluated effects of AF injury and FibGen repair on IVD and vertebral body structure and function using CT, MRI, histology, and biomechanical assessments.
The 1-month screening determined the applicability and the persistence of FibGen gel and PTMC scaffold within the AF defect since these biomaterials had previously been shown to have beneficial effects in an organ culture model of AF injury. 31 This current study showed dislocations of both the PTMC scaffold and the supporting PU membrane 1 month after surgery. This finding may be attributed to the more rigorous mechanical environment in the cervical IVD in vivo 15 compared to the merely axial simulated-physiological load that was applied in prior organ culture studies on isolated bovine IVDs. 31 FibGen repair had no negative effects at 1 month and the PU membrane was not necessary to prevent herniation. Consequently, the subsequent long-term study focused on the application of FibGen for repair of the AF defect. here. 40 Evidence for healing in Injured and FibGen samples are similar to a previous ovine study with a similar sample size with puncture and concentric tear injuries that exhibited significantly reduced bending stiffness after 1 month, followed by an increase in stiffness concurrent with lamellar thickening at 3, 6, 12, and 18 months. 42 The relatively high variance in biomechanical properties and relatively low sample size is a limitation of this study; the required sample size given an effect size of 0.3 and the observed SD (from 4 torque range measurement) is 44 which was cost prohibitive for this long-term in vivo study. Nevertheless, the Injured and FibGen had nearly identical mean values providing little suggestion that a difference would be detected even with an increased sample size. One limitation for this study was there was no fluid bath for these specimens which is known to change the measured response, as decreased water content due to osmotic loading reduces strain energy density and modulus of AF tissue. 42 Equivalent healing for FibGen and Injured are somewhat similar to prior results for fibrin. Fibrin sealant (Biostat BIOLOGX, Spinal Restorations) showed promise to repair denucleated porcine IVDs after 12 weeks in vivo 43 but then showed equivalency to saline injection in a Phase III clinical trial which was applied to treat single-level discogenic back pain in humans. 44, 45 FibGen degrades much more slowly than fibrin alone and we therefore expected FibGen to have greater potential for improved performance for AF repair and biomechanical restoration at 12 months. However, future testing in an injury model with fewer endplate effects will be required to better challenge FibGen and to test this concept.
In the long-term study, we observed irregular vertebral body bone formation starting at 3 months in both injured groups with no differ- 47, 48 suggesting additional evidence for heterotopic ossification in ovine in vivo models. Endplate changes were seen in response to scalpel blade incisions suggesting remodeling from AF injury and more severe IVD degeneration. 47, 48 Differences in cortical bone structure were also present in an enzyme induced degeneration model, 49 further suggesting IVD health affects vertebral body morphology.
Histological results also demonstrated equivalency between Injured and FibGen groups; however, there was also no evidence for hydrogel related complications. We adopted a scoring scheme which was sensitive to cell treated injured IVDs. 38 Qualitatively, AF structure appeared similar for FibGen and Injured, and there were no semiquantitative differences, suggesting that FibGen adhesive hydrogel was no more effective at restoring the AF structure than the natural healing process. Interestingly, intradiscal blood, blood vessels, and cellular influx were observed which likely resulted from the AF injury.
Intradiscal hemosiderin can result from bleeding concurrent to IVD injury and has been observed in the thoracic 50 and lumbar spine. 51 The healthy IVD has minimal vascularization, but increased vascularization is concurrent with degeneration 52 and may result from AF disruption. 53 Future studies in mouse could identify the phenotype and source of cells at the injury site. 53, 54 Interestingly, we observed higher Pfirrmann grade in Intact samples, which typically correlates with higher degeneration. 56 We also observed smaller disc height and larger disc height index for the Intact samples, likely due to naturally reduced disc height but possibly due to adjacent level effects. Previous observations of Merino sheep show less than 0.5 mm difference in average disc height between the cervical levels 56 which is in contrast to the 1 mm difference observed here. Measuring the disc height change longitudinally with higher resolution CT scanning and further normalizing 12 month to 0 month measurements may more accurately represent changes to disc height in each experimental group.
As a result, we conclude that intact samples must be controlled for level, and while intact MRI output measurements are presented, the most relevant comparisons are between Injured and FibGen groups which are controlled for level effects.
| CONCLUSIONS
This study applied a composite AF repair strategy to a 2-mm diameter biopsy punch injury in an in vivo ovine model to demonstrate that the PTMC scaffold herniated within 1-month while FibGen did not, motivating its further application for long-term repair. At 
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